trial

Effects of a Cognitive Rehabilitation Program: a Neurocognitive Study

NCTId NCT02201888
as of 2026-07-01
Add to landscapeMonitor thisAsk about this
at a glance
— · Completed
Enrollment 130 (actual)
Sponsored by Salvador Sarró, MD
Primary completion 2013-12
Synthesized from structured facts only — each point cited above.

Design & status

Phase
—
Status
Completed
Enrollment
130 (actual)
Study type
Interventional
Allocation
Randomized
Model
Parallel
Masking
Single
Start
2010-01
Primary completion
2013-12
Eligibility
ALL · 18 Years · 65 Years

Interventions & indications

Drugs
Computer-assisted cognitive trainingComputerized active condition

Sponsors

Salvador Sarró, MDLead Sponsor
Instituto de Salud Carlos IIICollaborator
Centro de Investigación Biomédica en Red de Salud MentalCollaborator
Hermanas Hospitalarias del Sagrado Corazón de Jesús, SpainCollaborator

Investigators

3
Peter J McKenna, MDStudy Director
Jesus J Gomar, PhDPrincipal Investigator
Edith Pomarol-Clotet, MD, PhDStudy Chair

Sites

1 total
Barcelona, Spain

Facts & assertions

4 sourced
Enrollment
130
Phase
NA
Primary Completion Date
2013-12
Status
COMPLETED
relationships
The graph out of here
drug
Computer-assisted cognitive training
drug
Computerized active condition
drug
lead_sponsor
Salvador Sarró, MD
company
collaborator
Instituto de Salud Carlos III
company
Centro de Investigación Biomédica en Red de Salud Mental
company
indication
Schizophrenia
indication
Schizophrenia
indication
investigator
Peter J McKenna, MD
person
Jesus J Gomar, PhD
person
Edith Pomarol-Clotet, MD, PhD
person